Profiel
Mr. Dalen Meeter is a Chief Financial Officer at Aspen Neuroscience, Inc. Mr. Meeter was previously employed as a Chief Financial & Accounting Officer by Singular Genomics Systems, Inc. and a Senior Director-Finance by Illumina, Inc. He received his undergraduate degree from the University of California, Santa Barbara and an MBA from USC Marshall School of Business.
Actieve functies van Dalen Meeter
| Bedrijven | Functie | Begin |
|---|---|---|
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Financieel Directeur/CFO | 10-03-2025 |
Eerdere bekende functies van Dalen Meeter
| Bedrijven | Functie | Einde |
|---|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Financieel Directeur/CFO | 21-02-2025 |
| ILLUMINA, INC. | Financieel Directeur/CFO | 06-01-2017 |
Opleiding van Dalen Meeter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
















